Study on Subcutaneous Blinatumomab for Treating Adults with CD19-Positive Mixed Phenotype Acute Leukemia (MPAL) | Clinical Trial

Study on Subcutaneous Blinatumomab for Treating Adults with CD19-Positive Mixed Phenotype Acute Leukemia (MPAL) | Clinical Trial | Right2Hope